Dauntless Pharmaceuticals Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Dauntless Pharmaceuticals General Information

Description

Developer of specialty therapeutics designed to offer a non-injectable somatostatin analog alternative. The company's therapeutics include inhibitors of growth hormone that are administered solely by injecting in approved products and is used as first-line pharmacotherapy for two orphan diseases, acromegaly and neuroendocrine tumors, enabling patients with a non-invasive alternative to benefit from short-acting therapy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 9920 Pacific Heights Boulevard
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dauntless Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 27-Oct-2021 0000 Completed Out of Business
2. Early Stage VC (Series A1) 09-Feb-2018 0000 0000 Completed Clinical Trials - General
1. Early Stage VC (Series A) 21-Jul-2015 $12M $12M Completed Startup
To view Dauntless Pharmaceuticals’s complete valuation and funding history, request access »

Dauntless Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of specialty therapeutics designed to offer a non-injectable somatostatin analog alternative. The company's th
Drug Discovery
San Diego, CA
2 As of 2020
0000
00000000 00 0000

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
0000 000000000
Singapore, Singapore
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000 000000000
Framingham, MA
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Dauntless Pharmaceuticals Competitors (38)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cerecin Venture Capital-Backed Singapore, Singapore 00 00000 00000000000 00000
0000000 Venture Capital-Backed Framingham, MA 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000000 Formerly VC-backed Cambridge, MA 00 0000 000000&0 0000
00000 000000000000 Formerly VC-backed Waltham, MA 000 00000 00000000 00000
You’re viewing 5 of 38 competitors. Get the full list »

Dauntless Pharmaceuticals Patents

Dauntless Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3713545-A1 Therapeutic compound formulations Inactive 22-Nov-2017 0000000000
US-20200281857-A1 Therapeutic compound formulations Inactive 22-Nov-2017 0000000000
EP-3713660-A1 Membrane emulsification device for microsphere creation Inactive 22-Nov-2017 0000000000
US-20200353419-A1 Membrane emulsification device for microsphere creation Inactive 22-Nov-2017 0000000000
EP-3630059-A1 Peptide compositions and methods of use Inactive 26-May-2017 A61K9/0043
To view Dauntless Pharmaceuticals’s complete patent history, request access »

Dauntless Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial